NCCN Consensus Guidelines for the Diagnosis and Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma. [electronic resource]
Producer: 20170606Description: 285-289 p. digitalISSN:- 1527-330X
- Anthracyclines -- therapeutic use
- Antibiotics, Antineoplastic -- therapeutic use
- Biopsy, Fine-Needle
- Breast Implantation -- adverse effects
- Breast Implants -- adverse effects
- Breast Neoplasms -- surgery
- Brentuximab Vedotin
- Chemotherapy, Adjuvant
- Female
- Humans
- Immunoconjugates -- therapeutic use
- Lymphatic Metastasis
- Lymphoma, Large-Cell, Anaplastic -- diagnosis
- Medical Oncology -- standards
- Neoplasm Staging
- Positron-Emission Tomography
- Surgery, Plastic -- standards
- Tomography, X-Ray Computed
No physical items for this record
Publication Type: Consensus Development Conference; Journal Article; Practice Guideline
There are no comments on this title.
Log in to your account to post a comment.